US FDA to hold advisory meeting to review Grail's multi-cancer test

Grail said on Friday the U.S. FDA ​plans to hold a ‌meeting of outside experts to review its multi-cancer screening test Galleri ​in September, sending its ​shares up 4% in morning ⁠trade.

本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。